HIV Induces TRAIL Sensitivity in Hepatocytes

Open Access

Peer-reviewed

Research Article

Challagundla K. Babu,

Affiliation Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Kanitta Suwansrinon,

Affiliation Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Gary D. Bren,

Affiliation Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Andrew D. Badley,

Affiliations Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, United States of America, Program in Translational Immunovirology and Biodefense, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Stacey A. Rizza

* E-mail: rizza.stacey@mayo.edu

Affiliations Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, United States of America, Program in Translational Immunovirology and Biodefense, Mayo Clinic, Rochester, Minnesota, United States of America
⨯

Reader Comments (0)

HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
Hepatocytes
Is the Subject Area "Hepatocytes" applicable to this article?

Thanks for your feedback.
HIV infections
Is the Subject Area "HIV infections" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Liver diseases
Is the Subject Area "Liver diseases" applicable to this article?

Thanks for your feedback.
Flow cytometry
Is the Subject Area "Flow cytometry" applicable to this article?

Thanks for your feedback.
Hepatitis C virus
Is the Subject Area "Hepatitis C virus" applicable to this article?

Thanks for your feedback.
Hepatitis B virus
Is the Subject Area "Hepatitis B virus" applicable to this article?

Thanks for your feedback.